CytomX Therapeutics (CTMX) Stock: Buy, Sell, or Hold?
$2.13
+0.15 (+7.58%)
▲
5d:
-9.36%
30d:
-8.39%
90d:
-36.42%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (88%)
Quality Score
50/100
Position
OVERSOLD
30-Day Fair Range
$2.17 – $2.48
Position: OVERSOLD
Forward P/E & Valuation
-4.1x
Next 12M consensus est.
Wall Street Target
$12.25
+475.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.90 / $2.42
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CTMX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CTMX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CTMX is currently trading at $2.13, which is considered oversold relative to its 30-day fair value range of $2.17 to $2.48.
Technical Outlook: Technically, CTMX is in a strong downtrend. Immediate support is located at $1.90, while resistance sits at $2.42. The stock is showing strong short-term momentum, up 7.6% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.25 (+475.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CTMX is in a strong downtrend. Immediate support is located at $1.90, while resistance sits at $2.42. The stock is showing strong short-term momentum, up 7.6% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.25 (+475.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.17 -
$2.48
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
Trading Range & Key Levels
30-Day Trading Range
$2.17 -
$2.48
Current vs Trading Range
OVERSOLD
Support Level
$1.90
Resistance Level
$2.42
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.6%)
- BULLISH: Trading 475.1% below Wall St target ($12.25)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-4.13
Wall Street Target
$12.25
(+475.1%)
Revenue Growth (YoY)
-71.7%
Earnings Growth (YoY)
60.6%
Share CTMX Analysis
Share this live CTMX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CTMX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user anticipates volatility in $CTMX until January, with buying pressure preventing significant price drops. No new news articles were found.
Key Retail Themes:
Volatility
January Timeframe
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:36 PM ET
Data refreshes hourly during market hours. Next update: 9:36 PM
Data refreshes hourly during market hours. Next update: 9:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTMX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 60 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CTMX Research Pages
